Stifel Financial Corp Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Stifel Financial Corp

$86.8 Billion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$144.95 - $152.29 $28,265 - $29,696	-195 Reduced 0.01%	3,071,644 $464 Million
Q2 2022 Aug 15, 2022	BUY	$83.14 - $145.99 $1.98 Million - $3.47 Million	23,771 Added 0.78%	3,071,839 $448 Million
Q1 2022 May 13, 2022	SELL	$110.08 - $142.92 $212,124 - $275,406	-1,927 Reduced 0.06%	3,048,068 $361 Million
Q4 2021 Feb 14, 2022	BUY	$99.73 - $148.48 $5.55 Million - $8.26 Million	55,650 Added 1.86%	3,049,995 $420 Million
Q3 2021 Nov 15, 2021	BUY	$98.85 - $138.91 $41.9 Million - $58.9 Million	424,304 Added 16.51%	2,994,345 $416 Million
Q2 2021 Aug 13, 2021	BUY	$65.78 - $105.02 $343,305 - $548,099	5,219 Added 0.2%	2,570,041 $249 Million
Q1 2021 May 14, 2021	BUY	$64.07 - $91.75 $1.43 Million - $2.05 Million	22,348 Added 0.88%	2,564,822 $175 Million
Q4 2020 Feb 12, 2021	BUY	$65.07 - $98.24 $939,025 - $1.42 Million	14,431 Added 0.57%	2,542,474 $218 Million
Q3 2020 Nov 16, 2020	BUY	$59.04 - $77.95 $2.18 Million - $2.88 Million	36,957 Added 1.48%	2,528,043 $164 Million
Q2 2020 Aug 14, 2020	SELL	$29.01 - $74.23 $10.1 Million - $25.8 Million	-347,460 Reduced 12.24%	2,491,086 $182 Million
Q1 2020 May 14, 2020	BUY	$27.51 - $57.29 $41,265 - $85,935	1,500 Added 0.05%	2,838,546 $96.6 Million
Q3 2019 Nov 13, 2019	SELL	$37.38 - $49.47 $55,770 - $73,809	-1,492 Reduced 0.05%	2,837,046 $118 Million
Q2 2019 Aug 14, 2019	BUY	$39.79 - $67.01 $457,585 - $770,615	11,500 Added 0.41%	2,838,538 $124 Million
Q1 2019 May 14, 2019	BUY	$34.52 - $53.29 $3.71 Million - $5.73 Million	107,500 Added 3.95%	2,827,038 $146 Million
Q4 2018 Feb 13, 2019	BUY	$29.75 - $42.9 $68.6 Million - $98.9 Million	2,304,438 Added 555.15%	2,719,538 $101 Million
Q1 2018 May 11, 2018	SELL	$22.49 - $34.56 $4,498 - $6,912	-200 Reduced 0.05%	415,100 $10.7 Million
Q3 2017 Nov 13, 2017	BUY	$23.54 - $38.21 $9.78 Million - $15.9 Million	415,300	415,300 $0

Others Institutions Holding BHVN

# of Institutions

Shares Held

785K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account